Gemcitabine and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemcitabine (gemcitabine) and Keppra (levetiracetam). Common drug interactions include bacteraemia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Gemcitabine and Keppra. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

On Jul, 09, 2026

52 people who take Gemcitabine and Keppra together, and have interactions are studied.

Gemcitabine and Keppra drug interactions.

What are the common drug interactions of Gemcitabine and Keppra, by gender? *:

female:

Bacteraemia (presence of bacteria in the blood)
Breath sounds
Cell death
Cerebral thrombosis (blood clot in brain)
Chills (felling of cold)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Fear
Gastritis (inflammation of stomach)

male:

Death
Anxiety
Cardiac disorder
Cellulitis (infection under the skin)
Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms)
Diarrhoea
Diplopia (double vision)
Fatigue (feeling of tiredness)
Haemorrhage (bleeding)
Headache (pain in head)

What are the common drug interactions of Gemcitabine and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Diplopia (double vision)
Discomfort
Dyspepsia (indigestion)
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Furuncle (infection of the hair follicle)
Gait disturbance
Haemorrhage (bleeding)
Headache (pain in head)
Malignant neoplasm progression (cancer tumour came back)

40-49:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Thrombocytopenia (decrease of platelets in blood)
Anaemia (lack of blood)
Cell death
Chills (felling of cold)
Death
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Hepatocellular injury (liver injury)
Hyperhidrosis (abnormally increased sweating)
Jaundice cholestatic

50-59:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Renal cell carcinoma (a kidney cancer)
Anxiety
Arthropathy
Cardiac disorder
Dyspnoea (difficult or laboured respiration)
Mobility decreased (ability to move is reduced)
Oedema peripheral (superficial swelling)
Pain
Respiratory disorder (respiratory disease)

60+:

Anaemia (lack of blood)
Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms)
Tremor (trembling or shaking movements in one or more parts of your body)
Weight decreased
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood pressure systolic increased
Body temperature decreased
Breath sounds

What are the existing conditions these people have? *

Pain: 9 people, 17.31%
Headache (pain in head): 8 people, 15.38%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 7 people, 13.46%
Stress And Anxiety: 7 people, 13.46%
Constipation: 7 people, 13.46%
Tumor: 6 people, 11.54%
Anaemia (lack of blood): 6 people, 11.54%
Neoplasm Malignant (cancer tumour): 6 people, 11.54%
Nausea (feeling of having an urge to vomit): 6 people, 11.54%
Brain Neoplasm Malignant (brain cancer tumour): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously